Yap Ching Chew

Yap Ching Chew has a long career in research and operations. From 2002 to 2008, they were a Graduate Research Assistant and Undergraduate Research Assistant at the University of Nebraska-Lincoln. During this time, they discovered five distinct biotinylation target sites in histone H2A, established the role of histone biotinylation in regulating the expression of retrotranspons, and developed a novel ELISA assay for quantifying histone debiotinylation. From 2008 to 2012, they were a Research Associate and Postdoctoral Fellow at the University of Maryland School of Medicine, where they published three first-authored papers, four co-authored papers, and one review paper, and identified a new mechanism whereby PKC delta regulates both skin cell proliferation and differentiation. From 2012 to 2015, they were a Scientist and Director of Epigenetics Technologies at Zymo Research Corp, where they managed a group of seven Scientist and Research Associates across multiple projects, oversaw and maintained Epigenetics product lines and ChIP-Seq services, and interacted with R&D scientists to facilitate technologies transfer to direct-to-consumer market and clinical market. Finally, from 2015 to present, they have been the Chief Operating Officer and Director at Pangea Laboratory.

Yap Ching Chew completed a B.S. in Nutritional Science and Dietetics from the University of Nebraska-Lincoln between 2001 and 2003. Yap Ching then attended Tunku Abdul Rahman College from 1999 to 2000, studying Biochemistry. In 2004, they obtained an M.S. in Molecular Nutrition from the University of Nebraska-Lincoln, followed by a Ph.D. in Molecular Nutrition from the same institution in 2008.